Major milestones in 2008

December
Contract signed with a top-10 pharma company for a ‘trusted broker’ service for the processing, management, evaluation and exchange of Quality Information (Quality Information Exchange - QIX).


June
Raffael Jovine, PhD, joins ii4sm as VP Head of Business Development.


May
Peter Schulz, MD, former global Head Drug Safety Operations at Roche joins ii4sm. Peter had executive positions in  pharmacovigilance & drug safety  at Amgen and Bayer Schering Pharma and brings a deep understanding on the drug safatey process to ii4sm.


April
Initiation of software development program for ii4sm’s innovative healthcare platform with computable semantic interoperability and SOA technology under the leadership of ii4sm’s Chief Technology Officer (CTO), Charles Mead, MD – who also holds the CTO position at the Center for Bioinformatics of the U.S. National Cancer Institute (NCI).


January
Legal foundation of ii4sm, the International Institute for the Safety of Medicines Ltd, Basel, Switzerland. Founding shareholders: Roland Haag, PhD (CEO), Pierre Jaccoud (Chairman), Thomas Hofmann (CFO), Thomas Engel (CIO).